Total Funding
67
66
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39914
AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis and fibrosis.
- Rachel Zayas: Founder, CEO
About the Company
AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis (NASH, liver disease) and fibrosis (liver scarring). AGED tools can simultaneously stage fibrosis and distinguish benign from severe liver disease (liver scarring). This method measures the concentration of target biomarkers (genetic signatures) in circulation using a
targeted genomic sequencing assessment. When biomarkers are detected over a specific quantity, liver disease (NASH) and/or fibrosis are diagnosed.
Women Founded
